Series C funding round for Kala Pharmaceuticals raising $68M in April 2016
Series C funding round for Kala Pharmaceuticals raising $68M in April 2016
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Angel | Dave Maki |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$109.2M
Top Valuation
-
Kala Pharmaceuticals raised $68M in a Series C round.
The round was announced on 04/01/16.
The round was led by Gregory Grunberg, M.D..